...
首页> 外文期刊>Psychopharmacology >Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
【24h】

Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.

机译:低训练剂量的氯氮平区分可将大鼠中的非典型药物与典型的抗精神病药物区分开。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

RATIONALE: Previous drug discrimination studies with clozapine have not reliably distinguished between atypical and typical antipsychotics. OBJECTIVES: The present study was conducted to determine whether low-dose clozapine drug discrimination could distinguish atypical from typical antipsychotics. METHODS: Rats were trained to discriminate 1.25 mg/kg clozapine from vehicle in a two-lever drug discrimination procedure. RESULTS: Generalization testing revealed full substitution with the atypical antipsychotics olanzapine (90.3% maximum generalization), sertindole (99.8%), and risperidone (87.1%) and partial substitution for quetiapine (seroquel, 66.4%) and the typical antipsychotics haloperidol (56.8%) and thioridazine (74.3%). Remoxipride (23.1%) and the typical antipsychotics chlorpromazine (27.9%) and fluphenazine (29.5%) did not reliably substitute for clozapine. CONCLUSIONS: In contrast to previous clozapine drug discrimination studies with higher training doses, the atypical antipsychotics olanzapine, sertindole, and risperidone reliably substituted for clozapine while typical antipsychotics did not. These results suggest that low-dose clozapine drug discrimination may be a more sensitive assay for distinguishing atypical from typical antipsychotic drugs.
机译:理由:以前使用氯氮平进行的药物歧视研究尚未可靠地区分非典型和典型的抗精神病药。目的:进行本研究是为了确定低剂量氯氮平药物歧视是否能区分非典型和典型的抗精神病药。方法:在两个杠杆的药物区分程序中,训练大鼠从媒介物中区分出1.25 mg / kg的氯氮平。结果:泛化测试显示,非典型抗精神病药奥氮平(最大泛化率为90.3%),赛多度(99.8%)和利培酮(87.1%)可以完全替代,而喹硫平(seroquel为66.4%)和典型的抗精神病药氟哌啶醇(56.8%)可以部分替代。 )和硫代哒嗪(74.3%)。雷莫昔必利(23.1%)和典型的抗精神病药物氯丙嗪(27.9%)和氟奋乃静(29.5%)不能可靠地替代氯氮平。结论:与以前的氯氮平药物歧视性研究相比,使用较高的训练剂量,非典型的抗精神病药奥氮平,塞地多尔和利培酮可以可靠地替代氯氮平,而典型的抗精神病药则不能。这些结果表明,低剂量的氯氮平药物区分可能是区分非典型药物和典型抗精神病药物的更灵敏的检测方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号